BridgeBio Pharma, Inc.BBIONASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.04B | +28.6% |
| 2024 | $811.00M | +32.0% |
| 2023 | $614.23M | +4.7% |
| 2022 | $586.42M | -8.8% |
| 2021 | $643.23M | +33.2% |
| 2020 | $482.73M | +58.6% |
| 2019 | $304.30M | +65.7% |
| 2018 | $183.66M | +318.8% |
| 2017 | $43.86M | - |